205 related articles for article (PubMed ID: 22020899)
1. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.
Cho HS; Toyokawa G; Daigo Y; Hayami S; Masuda K; Ikawa N; Yamane Y; Maejima K; Tsunoda T; Field HI; Kelly JD; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
Int J Cancer; 2012 Aug; 131(3):E179-89. PubMed ID: 22020899
[TBL] [Abstract][Full Text] [Related]
2. The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6.
Toyokawa G; Cho HS; Iwai Y; Yoshimatsu M; Takawa M; Hayami S; Maejima K; Shimizu N; Tanaka H; Tsunoda T; Field HI; Kelly JD; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
Cancer Prev Res (Phila); 2011 Dec; 4(12):2051-61. PubMed ID: 21930796
[TBL] [Abstract][Full Text] [Related]
3. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
Chen J; Zhang J; Yang J; Xu L; Hu Q; Xu C; Yang S; Jiang H
Atherosclerosis; 2017 Feb; 257():152-163. PubMed ID: 28135625
[TBL] [Abstract][Full Text] [Related]
4. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.
Dandawate P; Ghosh C; Palaniyandi K; Paul S; Rawal S; Pradhan R; Sayed AAA; Choudhury S; Standing D; Subramaniam D; Padhye SB; Gunewardena S; Thomas SM; Neil MO; Tawfik O; Welch DR; Jensen RA; Maliski S; Weir S; Iwakuma T; Anant S; Dhar A
Gastroenterology; 2019 Dec; 157(6):1646-1659.e11. PubMed ID: 31442435
[TBL] [Abstract][Full Text] [Related]
5. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
Toyokawa G; Cho HS; Masuda K; Yamane Y; Yoshimatsu M; Hayami S; Takawa M; Iwai Y; Daigo Y; Tsuchiya E; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
Neoplasia; 2011 Oct; 13(10):887-98. PubMed ID: 22028615
[TBL] [Abstract][Full Text] [Related]
6. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract][Full Text] [Related]
7. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
Ramadoss S; Guo G; Wang CY
Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
[TBL] [Abstract][Full Text] [Related]
8. Histone Demethylase KDM3 (JMJD1) in Transcriptional Regulation and Cancer Progression.
Fan L; Sudeep K; Qi J
Adv Exp Med Biol; 2023; 1433():69-86. PubMed ID: 37751136
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway.
Hayami S; Yoshimatsu M; Veerakumarasivam A; Unoki M; Iwai Y; Tsunoda T; Field HI; Kelly JD; Neal DE; Yamaue H; Ponder BA; Nakamura Y; Hamamoto R
Mol Cancer; 2010 Mar; 9():59. PubMed ID: 20226085
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A.
Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y
J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503
[TBL] [Abstract][Full Text] [Related]
11. Histone demethylase JMJD1A in cancer progression and therapeutic resistance.
Jeon HY; Ryu H; Pornour M; Qi J
Mol Carcinog; 2022 Apr; 61(4):392-396. PubMed ID: 35020958
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition.
Kogure M; Takawa M; Cho HS; Toyokawa G; Hayashi K; Tsunoda T; Kobayashi T; Daigo Y; Sugiyama M; Atomi Y; Nakamura Y; Hamamoto R
Cancer Lett; 2013 Aug; 336(1):76-84. PubMed ID: 23603248
[TBL] [Abstract][Full Text] [Related]
13. ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1.
Mahajan K; Lawrence HR; Lawrence NJ; Mahajan NP
J Biol Chem; 2014 Oct; 289(41):28179-91. PubMed ID: 25148682
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles-encapsulated let-7i shed from bone mesenchymal stem cells suppress lung cancer via KDM3A/DCLK1/FXYD3 axis.
Liu J; Feng Y; Zeng X; He M; Gong Y; Liu Y
J Cell Mol Med; 2021 Feb; 25(4):1911-1926. PubMed ID: 33350586
[TBL] [Abstract][Full Text] [Related]
15. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.
Zhao QY; Lei PJ; Zhang X; Zheng JY; Wang HY; Zhao J; Li YM; Ye M; Li L; Wei G; Wu M
Clin Epigenetics; 2016; 8():34. PubMed ID: 27034728
[TBL] [Abstract][Full Text] [Related]
16. The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.
Kang D; Cho HS; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Hayami S; Tsunoda T; Field HI; Matsuda K; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
Genes Chromosomes Cancer; 2013 Feb; 52(2):126-39. PubMed ID: 23011637
[TBL] [Abstract][Full Text] [Related]
17. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
[TBL] [Abstract][Full Text] [Related]
18. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
[TBL] [Abstract][Full Text] [Related]
19. The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.
Wade MA; Jones D; Wilson L; Stockley J; Coffey K; Robson CN; Gaughan L
Nucleic Acids Res; 2015 Jan; 43(1):196-207. PubMed ID: 25488809
[TBL] [Abstract][Full Text] [Related]
20. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
Lee KH; Kim BC; Jeong SH; Jeong CW; Ku JH; Kim HH; Kwak C
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
